The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED)

PHASE2RecruitingINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG

Colchicine

0.5 mg once daily

DRUG

Placebo

Once daily

Trial Locations (1)

RECRUITING

Center for Translational Cardiology and Pragmatic Randomized Trials, Herlev and Gentofte Hospital, Hellerup

All Listed Sponsors

lead

Tor Biering-Sørensen

OTHER